CorMedix Inc. (CRMD) › Shares OutstandingCorMedix Inc. (CRMD) — Shares OutstandingAnnual figures by period end, from SEC filings.2010-12-31: 11.41M2011-12-31: 11.41M2012-12-31: 11.41M2013-12-31: 16.61M2014-12-31: 22.46M2015-12-31: 35.96M2016-12-31: 40.43M2017-12-31: 71.41M2018-12-31: 21.78M2019-12-31: 25.67M2020-12-31: 33.56M2021-12-31: 38.09M2022-12-31: 42.82M2023-12-31: 54.94M2024-12-31: 64.41M2025-12-31: 79.26M79.26M2010-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3179.26M+23.1%2026-03-05Balance as of period end2024-12-3164.41M+17.2%2026-03-05Balance as of period end2023-12-3154.94M+28.3%2025-03-25Balance as of period end2022-12-3142.82M+12.4%2024-03-12Balance as of period end2021-12-3138.09M+13.5%2023-03-30Balance as of period end2020-12-3133.56M+30.8%2022-03-29Balance as of period end2019-12-3125.67M+17.9%2021-03-30Balance as of period end2018-12-3121.78M-69.5%2020-03-16Balance as of period end2017-12-3171.41M+76.6%2019-05-29Balance as of period end2016-12-3140.43M+12.4%2018-03-19Balance as of period end2015-12-3135.96M+60.1%2017-03-16Balance as of period end2014-12-3122.46M+35.3%2016-03-15Balance as of period end2013-12-3116.61M+45.6%2015-03-12Balance as of period end2012-12-3111.41M+0.0%2014-03-31Balance as of period end2011-12-3111.41M+0.0%2014-03-04Balance as of period end2010-12-3111.41M—2012-04-26Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)